Use of pragmatic and explanatory trial designs in acute care research: lessons from COVID-19.

Use of pragmatic and explanatory trial designs in acute care research: lessons from COVID-19.
复制标题

在急性护理研究中使用实用和解释性试验设计:COVID-19的教训。

DOI:
10.1016/s2213-2600(22)00044-3
复制
发表时间:
2022-07
影响因子:
76.2
通讯作者:
Collins, Sean P.
Collins, Sean P.
中科院分区:
医学1区
文献类型:
--
作者:
Casey, Jonathan D.;Beskow, Laura M.;Brown, Jeremy;Brown, Samuel M.;Gayat, Etienne;Gong, Michelle Ng;Harhay, Michael O.;Jaber, Samir;Jentzer, Jacob C.;Laterre, Pierre-Francois;Marshall, John C.;Matthay, Michael A.;Rice, Todd W.;Rosenberg, Yves;Turnbull, Alison E.;Ware, Lorraine B.;Self, Wesley H.;Mebazaa, Alexandre;Collins, Sean P.

文献摘要

参考文献

被引文献

相似文献

在进行临床试验以评估已在临床上普遍使用的疗法时,会出现独特的挑战,包括由于试验疗法的广泛开放标签使用而难以招募患者,以及需要大样本量来检测小但有临床意义的治疗效果。尽管在评估疫苗等新型干预措施的试验中取得了许多成功,但传统的解释性试验一直难以为COVID-19急性病患者的时间敏感性问题提供明确的答案。越来越多的人建议将实用性试验作为评价临床常用疗法的一种手段,它可以通过将部分或全部试验程序嵌入临床护理来提高效率。在这篇个人观点中,我们使用两项同时进行的COVID-19羟氯喹试验(美国ORCHID试验和英国RECOVERY试验)来对比解释性和实用性试验设计对试验实施、试验结果以及临床试验外管理的患者护理的影响。鉴于解释性和实用性试验设计的潜在优点和缺点,我们提出了在急性护理环境中评估治疗方法的最佳使用建议。
Unique challenges arise when conducting trials to evaluate therapies already in common clinical use, including difficulty enrolling patients owing to widespread open-label use of trial therapies and the need for large sample sizes to detect small but clinically meaningful treatment effects. Despite numerous successes in trials evaluating novel interventions such as vaccines, traditional explanatory trials have struggled to provide definitive answers to time-sensitive questions for acutely ill patients with COVID-19. Pragmatic trials, which can increase efficiency by allowing some or all trial procedures to be embedded into clinical care, are increasingly proposed as a means to evaluate therapies that are in common clinical use. In this Personal View, we use two concurrently conducted COVID-19 trials of hydroxychloroquine (the US ORCHID trial and the UK RECOVERY trial) to contrast the effects of explanatory and pragmatic trial designs on trial conduct, trial results, and the care of patients managed outside of clinical trials. In view of the potential advantages and disadvantages of explanatory and pragmatic trial designs, we make recommendations for their optimal use in the evaluation of therapies in the acute care setting.
DOI: 10.1177/0885066617720159
发表时间: 2019-11
影响因子: 3.1
作者:
McKown AC;Brown RM;Ware LB;Wanderer JP
通讯作者: Wanderer JP